EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Activity of novel antibiotics against dual metallo-Beta-lactamase producing Enterobacter hormaechei clinical isolates

Camila Solar, Lorena Diaz, Katherine Soto, Jose R W Martínez, Nicolas Canales, Yehudit Bergman iD, Anne Peters, Rafael Araos, Patricia García iD, Pranita D Tamma iD, Jose M Munita iD

JAC-Antimicrobial Resistance · 07.01.2026 · 8 (1)

DOI: 10.1093/jacamr/dlaf252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 21.01.2026. Verfasst von Camila Solar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Genomics & Resistant Microbes Group (GeRM), Instituto de Ciencias e Innovación en Medicina (ICIM), Facultad de Medicina Clínica Alemana, Universidad …. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: FONDECYT, Beca Doctorado Nacional, ANID.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metallo-β-lactamase (MBL)-producing carbapenemase-resistant Enterobacterales infections are associated with significant mortality. Several β-lactam/β-lactamase inhibitor combinations (BL/BLI) with promising activity against MBLs are in the pipeline.

Objective

To investigate the in vitro activity of upcoming BL/BLI agents against Enterobacter hormaechei clinical isolates co-producing NDM and VIM enzymes.

Methods

Eleven E. hormaechei isolates co-harbouring blaNDM-7 and blaVIM-1 were identified from 10 patients admitted to a tertiary hospital in Santiago, Chile, between July 2022 and July 2023. Reference broth microdilution (BMD) panels were developed to determine minimum inhibitory concentrations (MICs) to aztreonam/avibactam, cefepime/taniborbactam, cefepime/zidebactam, cefiderocol and cefiderocol/xeruborbactam. Cefiderocol population analysis profile–area under the curve (PAP–AUC) was performed in strains exhibiting cefiderocol susceptibility to assess for cefiderocol heteroresistance. Long-read sequencing, using the Oxford Nanopore Technologies platform, was conducted on all isolates to characterize the genomic background of blaNDM-7 and blaVIM-1.

Results

Among the 11 E. hormaechei isolates assemblies revealed blaNDM-7 and blaVIM-1 were located on separate plasmids. All isolates were susceptible to aztreonam/avibactam, cefepime/taniborbactam and cefepime/zidebactam. Cefiderocol susceptibility was variable; the addition of xeruborbactam restored susceptibility.

Conclusions

Our findings indicate that E. hormaechei clinical isolates co-producing NDM and VIM metallo-carbapenemases exhibited susceptibility to all tested novel BL/BLIs, including aztreonam/avibactam, cefepime/taniborbactam and cefepime/zidebactam. The combination of cefiderocol and xeruborbactam restored the activity of cefiderocol.

Autor:innen und Institutionen

  • Genomics & Resistant Microbes Group (GeRM), Instituto de Ciencias e Innovación en Medicina (ICIM), Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
  • Multidisciplinary Initiative for Collaborative Research on Bacterial Resistance (MICROB-R), Santiago, Chile.
  • Center for Bioinformatics and Integrative Biology, Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile.
  • Department of Pediatrics, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Departamento de Laboratorios Clínicos, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.

ORCID-Profile: Yehudit Bergman, Patricia García, Pranita D Tamma, Jose M Munita

Förderung

  • FONDECYT
  • Beca Doctorado Nacional
  • ANID

Zitieren

APA

Solar, C., Diaz, L., Soto, K., Martínez, J. R. W., Canales, N., Bergman, Y., Peters, A., Araos, R., García, P., Tamma, P. D., & Munita, J. M. (2026). Activity of novel antibiotics against dual metallo-Beta-lactamase producing Enterobacter hormaechei clinical isolates. JAC-Antimicrobial Resistance, 8(1). https://doi.org/10.1093/jacamr/dlaf252

Vancouver

Solar C, Diaz L, Soto K, Martínez JRW, Canales N, Bergman Y, et al. Activity of novel antibiotics against dual metallo-Beta-lactamase producing Enterobacter hormaechei clinical isolates. JAC-Antimicrobial Resistance. 2026;8(1). doi:10.1093/jacamr/dlaf252

BibTeX
@article{Solar2026,
  author = {Solar, Camila and Diaz, Lorena and Soto, Katherine and Martínez, Jose R W and Canales, Nicolas and Bergman, Yehudit and Peters, Anne and Araos, Rafael and García, Patricia and Tamma, Pranita D and Munita, Jose M},
  title = {Activity of novel antibiotics against dual metallo-Beta-lactamase producing Enterobacter hormaechei clinical isolates},
  journal = {JAC-Antimicrobial Resistance},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1093/jacamr/dlaf252}
}
Kostenlos starten →